Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Myocarditis | Research

Clinical characteristics and influencing factors of severe fever with thrombocytopenia syndrome complicated by viral myocarditis: a retrospective study

Authors: Qian Du, Jin Yu, Qianhui Chen, Xiaoping Chen, Qunqun Jiang, Liping Deng, Anling Li, Yong Xiong

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Objective

This study aimed to investigate the clinical characteristics of severe fever with thrombocytopenia syndrome complicated by viral myocarditis (SFTS-VM) and analyze relevant influencing factors.

Methods

Retrospective analysis was conducted on clinical data from 79 SFTS-VM patients, categorized into common (SFTS-CVM, n = 40) and severe groups (SFTS-SVM, n = 39). Clinical manifestations, laboratory results, cardiac ultrasonography, and electrocardiogram features were analyzed. Univariate and multivariate analyses identified significant indicators, which were further assessed using ROC curves to predict SFTS-SVM.

Results

SFTS-SVM group exhibited higher rates of hypotension, shock, abdominal pain, cough with sputum, and consciousness disorders compared to SFTS-CVM group. Laboratory findings showed elevated platelet count, ALT, AST, amylase, lipase, LDH, D-dimer, procalcitonin, TNI, and NT-proBNP in SFTS-SVM. Abnormal electrocardiograms, especially atrial fibrillation, were more prevalent in SFTS-SVM (P < 0.05). Multivariate analysis identified elevated LDH upon admission (OR = 1.004, 95% CI: 1-1.008, P = 0.050), elevated NT-proBNP (OR = 1.005, 95% CI: 1.001–1.008, P = 0.007), and consciousness disorders (OR = 112.852, 95% CI: 3.676 ~ 3464.292, P = 0.007) as independent risk factors for SFTS-SVM. LDH and NT-proBNP had AUCs of 0.728 and 0.744, respectively, in predicting SFTS-SVM. Critical values of LDH (> 978.5U/L) and NT-proBNP (> 857.5pg/ml)) indicated increased likelihood of SFTS progression into SVM.

Conclusion

Elevated LDH, NT-proBNP, and consciousness disorders independently correlate with SFTS-SVM. LDH and NT-proBNP can aid in early identification of SFTS-SVM development when above specified thresholds.
Literature
1.
go back to reference Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523–32.CrossRefPubMedPubMedCentral Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523–32.CrossRefPubMedPubMedCentral
2.
go back to reference China MoHotPsRo.: [Guidelines for prevention and treatment of fever with thrombocytopenia syndrome (2010 edition)]. Chin J Clin Infect Dis 2011(04):193–4. China MoHotPsRo.: [Guidelines for prevention and treatment of fever with thrombocytopenia syndrome (2010 edition)]. Chin J Clin Infect Dis 2011(04):193–4.
3.
go back to reference Chen QL, Zhu MT, Chen N, Yang D, Yin WW, Mu D, Li Y, Zhang YP, Zainawudong Y. [Epidemiological characteristics of severe fever with Thtrombocytopenia syndrome in China, 2011–2021]. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(6):852–9.PubMed Chen QL, Zhu MT, Chen N, Yang D, Yin WW, Mu D, Li Y, Zhang YP, Zainawudong Y. [Epidemiological characteristics of severe fever with Thtrombocytopenia syndrome in China, 2011–2021]. Zhonghua Liu Xing Bing Xue Za Zhi. 2022;43(6):852–9.PubMed
4.
go back to reference Cui N, Liu R, Lu QB, Wang LY, Qin SL, Yang ZD, Zhuang L, Liu K, Li H, Zhang XA, et al. Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis. J Infect. 2015;70(1):52–9.CrossRefPubMed Cui N, Liu R, Lu QB, Wang LY, Qin SL, Yang ZD, Zhuang L, Liu K, Li H, Zhang XA, et al. Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis. J Infect. 2015;70(1):52–9.CrossRefPubMed
5.
go back to reference Yoo JR, Heo ST, Song SW, Bae SG, Lee S, Choi S, Lee C, Jeong S, Kim M, Sa W, et al. Severe fever with Thrombocytopenia Syndrome Virus in Ticks and SFTS incidence in humans, South Korea. Emerg Infect Dis. 2020;26(9):2292–4.CrossRefPubMedPubMedCentral Yoo JR, Heo ST, Song SW, Bae SG, Lee S, Choi S, Lee C, Jeong S, Kim M, Sa W, et al. Severe fever with Thrombocytopenia Syndrome Virus in Ticks and SFTS incidence in humans, South Korea. Emerg Infect Dis. 2020;26(9):2292–4.CrossRefPubMedPubMedCentral
6.
go back to reference Caforio AL, Marcolongo R, Basso C, Iliceto S. Clinical presentation and diagnosis of myocarditis. Heart. 2015;101(16):1332–44.CrossRefPubMed Caforio AL, Marcolongo R, Basso C, Iliceto S. Clinical presentation and diagnosis of myocarditis. Heart. 2015;101(16):1332–44.CrossRefPubMed
7.
go back to reference Kim UJ, Park H, Kim KH, Kim DM, Kim SE, Kang SJ, Park K-H. In Jung S: Veno-arterial extracorporeal membrane oxygenation for severe fever with thrombocytopenia syndrome with fulminant myocarditis: a case report. BMC Infect Dis 2021, 21(1):803. Kim UJ, Park H, Kim KH, Kim DM, Kim SE, Kang SJ, Park K-H. In Jung S: Veno-arterial extracorporeal membrane oxygenation for severe fever with thrombocytopenia syndrome with fulminant myocarditis: a case report. BMC Infect Dis 2021, 21(1):803.
8.
go back to reference Sheng Y, Zhao XL, Xu YY, Jin DQ. [Fulminant myocarditis caused by severe fever with thrombocytopenia syndrome bunyavirus in a child]. Zhonghua Er Ke Za Zhi. 2022;60(7):717–8.PubMed Sheng Y, Zhao XL, Xu YY, Jin DQ. [Fulminant myocarditis caused by severe fever with thrombocytopenia syndrome bunyavirus in a child]. Zhonghua Er Ke Za Zhi. 2022;60(7):717–8.PubMed
9.
go back to reference Miyamoto S, Ito T, Terada S, Eguchi T, Furubeppu H, Kawamura H, Yasuda T, Kakihana Y. Fulminant myocarditis associated with severe fever with thrombocytopenia syndrome: a case report. BMC Infect Dis. 2019;19(1):266.CrossRefPubMedPubMedCentral Miyamoto S, Ito T, Terada S, Eguchi T, Furubeppu H, Kawamura H, Yasuda T, Kakihana Y. Fulminant myocarditis associated with severe fever with thrombocytopenia syndrome: a case report. BMC Infect Dis. 2019;19(1):266.CrossRefPubMedPubMedCentral
10.
go back to reference Okutsu S, Futami M, Arimura T, Ohki K, Hiyoshi T, Sakihara E, Kato Y, Ueda Y, Yano M, Takeshita M, et al. Acute myocarditis with severe fever and Thrombocytopenia Syndrome. Intern Med. 2022;61(11):1779–84.CrossRefPubMedPubMedCentral Okutsu S, Futami M, Arimura T, Ohki K, Hiyoshi T, Sakihara E, Kato Y, Ueda Y, Yano M, Takeshita M, et al. Acute myocarditis with severe fever and Thrombocytopenia Syndrome. Intern Med. 2022;61(11):1779–84.CrossRefPubMedPubMedCentral
11.
go back to reference branch CMAID.: [Consensus on diagnosis and treatment of fever with thrombocytopenia syndrome]. Chin J Infect Dis 2022(12):711–21. branch CMAID.: [Consensus on diagnosis and treatment of fever with thrombocytopenia syndrome]. Chin J Infect Dis 2022(12):711–21.
12.
go back to reference Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial diseases. Eur Heart J. 2013;34(33):2636–48. 2648a-2648d.CrossRefPubMed Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Helio T, Heymans S, Jahns R, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial diseases. Eur Heart J. 2013;34(33):2636–48. 2648a-2648d.CrossRefPubMed
13.
go back to reference group CJoCDEBcs. Reference criteria for the diagnosis of acute viral myocarditis in adults and the adoption of the World Health Organization and International Federation of Cardiology Working Group on the definition and classification of cardiomyopathy. Chin J Cardiovasc Dis. 1999;6:4–6. group CJoCDEBcs. Reference criteria for the diagnosis of acute viral myocarditis in adults and the adoption of the World Health Organization and International Federation of Cardiology Working Group on the definition and classification of cardiomyopathy. Chin J Cardiovasc Dis. 1999;6:4–6.
14.
go back to reference Kwon JS, Kim MC, Kim JY, Jeon NY, Ryu BH, Hong J, Kim MJ, Chong YP, Lee SO, Choi SH, et al. Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome. J Clin Virol. 2018;101:57–62.CrossRefPubMedPubMedCentral Kwon JS, Kim MC, Kim JY, Jeon NY, Ryu BH, Hong J, Kim MJ, Chong YP, Lee SO, Choi SH, et al. Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome. J Clin Virol. 2018;101:57–62.CrossRefPubMedPubMedCentral
15.
go back to reference Yoo JR, Kim T-J, Heo ST, Hwang K-A, Oh H, Ha T, Ko HK, Baek S, Kim JE, Kim JH, et al. IL-6 and IL-10 levels, rather than viral load and neutralizing antibody titers, determine the fate of patients with severe fever with Thrombocytopenia Syndrome Virus infection in South Korea. Front Immunol. 2021;12:711847.CrossRefPubMedPubMedCentral Yoo JR, Kim T-J, Heo ST, Hwang K-A, Oh H, Ha T, Ko HK, Baek S, Kim JE, Kim JH, et al. IL-6 and IL-10 levels, rather than viral load and neutralizing antibody titers, determine the fate of patients with severe fever with Thrombocytopenia Syndrome Virus infection in South Korea. Front Immunol. 2021;12:711847.CrossRefPubMedPubMedCentral
16.
go back to reference Kang SY, Yoo JR, Park Y, Kim SH, Heo ST, Park SH, Kim M, Kim TJ, Oh S, Lee MS, et al. Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-beta. J Med Virol. 2023;95(7):e28894.CrossRefPubMed Kang SY, Yoo JR, Park Y, Kim SH, Heo ST, Park SH, Kim M, Kim TJ, Oh S, Lee MS, et al. Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-beta. J Med Virol. 2023;95(7):e28894.CrossRefPubMed
17.
go back to reference Li S, Li Y, Wang Q, Yu X, Liu M, Xie H, Qian L, Ye L, Yang Z, Zhang J, et al. Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case. Virol J. 2018;15(1):97.CrossRefPubMedPubMedCentral Li S, Li Y, Wang Q, Yu X, Liu M, Xie H, Qian L, Ye L, Yang Z, Zhang J, et al. Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case. Virol J. 2018;15(1):97.CrossRefPubMedPubMedCentral
18.
go back to reference Yajima T. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol. 2011;6(5):551–66.CrossRefPubMed Yajima T. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection. Future Microbiol. 2011;6(5):551–66.CrossRefPubMed
19.
go back to reference Liu MM, Lei XY, Yu H, Zhang JZ, Yu XJ. Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome. Virol J. 2017;14(1):6.CrossRefPubMedPubMedCentral Liu MM, Lei XY, Yu H, Zhang JZ, Yu XJ. Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome. Virol J. 2017;14(1):6.CrossRefPubMedPubMedCentral
20.
go back to reference Sun Y, Jin C, Zhan F, Wang X, Liang M, Zhang Q, Ding S, Guan X, Huo X, Li C, et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis. 2012;206(7):1085–94.CrossRefPubMed Sun Y, Jin C, Zhan F, Wang X, Liang M, Zhang Q, Ding S, Guan X, Huo X, Li C, et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis. 2012;206(7):1085–94.CrossRefPubMed
21.
go back to reference Choi SJ, Park SW, Bae IG, Kim SH, Ryu SY, Kim HA, Jang HC, Hur J, Jun JB, Jung Y, et al. Severe fever with Thrombocytopenia Syndrome in South Korea, 2013–2015. PLoS Negl Trop Dis. 2016;10(12):e0005264.CrossRefPubMedPubMedCentral Choi SJ, Park SW, Bae IG, Kim SH, Ryu SY, Kim HA, Jang HC, Hur J, Jun JB, Jung Y, et al. Severe fever with Thrombocytopenia Syndrome in South Korea, 2013–2015. PLoS Negl Trop Dis. 2016;10(12):e0005264.CrossRefPubMedPubMedCentral
22.
go back to reference Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Voll RE, Goppert N, Ciminski K, Kreutz C, Lother A, Salzer U, et al. Circulating multimeric immune complexes contribute to immunopathology in COVID-19. Nat Commun. 2022;13(1):5654.ADSCrossRefPubMedPubMedCentral Ankerhold J, Giese S, Kolb P, Maul-Pavicic A, Voll RE, Goppert N, Ciminski K, Kreutz C, Lother A, Salzer U, et al. Circulating multimeric immune complexes contribute to immunopathology in COVID-19. Nat Commun. 2022;13(1):5654.ADSCrossRefPubMedPubMedCentral
23.
go back to reference Yoo JR, Kim J-Y, Heo ST, Kim J, Park H-J, Lee J-Y, Lim H-Y, Park W-J, Cho N-H, Kim JM, et al. Neutralizing antibodies to severe fever with Thrombocytopenia Syndrome Virus among Survivors, non-survivors and healthy residents in South Korea. Front Cell Infect Microbiol. 2021;11:649570.CrossRefPubMedPubMedCentral Yoo JR, Kim J-Y, Heo ST, Kim J, Park H-J, Lee J-Y, Lim H-Y, Park W-J, Cho N-H, Kim JM, et al. Neutralizing antibodies to severe fever with Thrombocytopenia Syndrome Virus among Survivors, non-survivors and healthy residents in South Korea. Front Cell Infect Microbiol. 2021;11:649570.CrossRefPubMedPubMedCentral
24.
go back to reference Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W, Zhang F, Li C, Zhang Q, Zhu H, et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A. 2012;109(25):10053–8.ADSCrossRefPubMedPubMedCentral Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W, Zhang F, Li C, Zhang Q, Zhu H, et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A. 2012;109(25):10053–8.ADSCrossRefPubMedPubMedCentral
25.
go back to reference Deng B, Zhou B, Zhang S, Zhu Y, Han L, Geng Y, Jin Z, Liu H, Wang D, Zhao Y, et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS ONE. 2013;8(11):e80802.ADSCrossRefPubMedPubMedCentral Deng B, Zhou B, Zhang S, Zhu Y, Han L, Geng Y, Jin Z, Liu H, Wang D, Zhao Y, et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS ONE. 2013;8(11):e80802.ADSCrossRefPubMedPubMedCentral
26.
go back to reference Yonghao LAN, Ma ZM. Analysis of early ECG characteristics of adult fulminant myocarditis. Int J Cardiol. 2018;45(05):304–7. Yonghao LAN, Ma ZM. Analysis of early ECG characteristics of adult fulminant myocarditis. Int J Cardiol. 2018;45(05):304–7.
27.
go back to reference Gai ZT, Zhang Y, Liang MF, Jin C, Zhang S, Zhu CB, Li C, Li XY, Zhang QF, Bian PF, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 2012;206(7):1095–102.CrossRefPubMed Gai ZT, Zhang Y, Liang MF, Jin C, Zhang S, Zhu CB, Li C, Li XY, Zhang QF, Bian PF, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 2012;206(7):1095–102.CrossRefPubMed
28.
go back to reference Abrar S, Ansari MJ, Mittal M, Kushwaha KP. Predictors of mortality in Paediatric myocarditis. J Clin Diagn Res. 2016;10(6):C12–16. Abrar S, Ansari MJ, Mittal M, Kushwaha KP. Predictors of mortality in Paediatric myocarditis. J Clin Diagn Res. 2016;10(6):C12–16.
29.
go back to reference Li J, Han Y, Xing Y, Li S, Kong L, Zhang Y, Zhang L, Liu N, Wang Q, Wang S, et al. Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome. PLoS ONE. 2014;9(3):e91679.ADSCrossRefPubMedPubMedCentral Li J, Han Y, Xing Y, Li S, Kong L, Zhang Y, Zhang L, Liu N, Wang Q, Wang S, et al. Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome. PLoS ONE. 2014;9(3):e91679.ADSCrossRefPubMedPubMedCentral
30.
go back to reference Xu Y, Shao M, Liu N, Dong D, Tang J, Gu Q. Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study. BMC Infect Dis. 2021;21(1):904.CrossRefPubMedPubMedCentral Xu Y, Shao M, Liu N, Dong D, Tang J, Gu Q. Clinical feature of severe fever with thrombocytopenia syndrome (SFTS)-associated encephalitis/encephalopathy: a retrospective study. BMC Infect Dis. 2021;21(1):904.CrossRefPubMedPubMedCentral
31.
go back to reference Engin A, Yilmaz MB, Elaldi N, Erdem A, Yalta K, Tandogan I, Kaya S, Bakir M, Dokmetas I. Crimean-Congo hemorrhagic fever: does it involve the heart? Int J Infect Dis. 2009;13(3):369–73.CrossRefPubMed Engin A, Yilmaz MB, Elaldi N, Erdem A, Yalta K, Tandogan I, Kaya S, Bakir M, Dokmetas I. Crimean-Congo hemorrhagic fever: does it involve the heart? Int J Infect Dis. 2009;13(3):369–73.CrossRefPubMed
Metadata
Title
Clinical characteristics and influencing factors of severe fever with thrombocytopenia syndrome complicated by viral myocarditis: a retrospective study
Authors
Qian Du
Jin Yu
Qianhui Chen
Xiaoping Chen
Qunqun Jiang
Liping Deng
Anling Li
Yong Xiong
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09096-4

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.